课题基金 / 基金详情

CAREER: qBio+cBio=sBio; Identifying the role of cross-family signaling in angiogenesis

CAREER: qBio+cBio=sBio; Identifying the role of cross-family signaling in angiogenesis
职业生涯:qBio cBio=sBio;
批准号:
2344705
负责人:
Princess Imoukhuede
金额:
$36.8万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-10-01 至 2024-12-31

项目摘要

项目成果

Princess Imoukhuede的其他基金

相似基金

相关文献

中文摘要
翻译
PI:Imoukhueed公主提案#:1653925生物医学工程中的一个关键挑战是需要控制血管形成的过程,也被称为“血管生成”。控制血管生成很重要,因为血管为我们的器官和组织正常运作提供必要的营养。控制癌症血管生成的努力集中在饥饿,并可能通过切断肿瘤血液供应来杀死肿瘤,通常是通过观察单一蛋白质。该项目提议通过解决一个更困难的“大数据”类问题来克服目前这类癌症治疗的局限性,并通过解决一个更困难的“大数据”类问题来满足控制血管生成的一般挑战:了解蛋白质组合如何控制血管生成。该项目将通过以下方式解决这个问题:1)通过实验确定重要的蛋白质特性;2)确定描述这些蛋白质行为的数学方程;以及3)开发包括实验数据和数学方程的计算机模拟,以确定蛋白质如何工作以引起血管生成。该项目的教育和推广部分将在入门课程中向二年级学生介绍研究和计算机建模,以激发他们对STEM的兴趣。这些活动将包括指导未被充分代表的学生,以提高他们对STEM专业的兴趣和毅力。由于直接控制血管生成涉及70多种疾病的病理,因此仍然是迫切需要的。血管生成控制的一种有前景的方法是超越传统的强调血管内皮生长因子(VEGFR)-血管内皮生长因子受体(VEGFR)轴的方法,转向一个新的焦点:跨轴信号转导(蛋白质跨家族结合)。这个项目的目标是通过建立在定量生物学(QBio)、概念性生物学(CBio)和整合系统生物学(SBIO)基础上的三个目标来实现向理解跨轴血管生成信号的转变。定量生物学将被用于测量跨轴结合和浓度或相关蛋白质配体,包括通过开发多路测量受体浓度的新的定量工具。计算生物学将被用来构建有效的跨轴模型,该模型将预测适配器激活如何对血管生成标志、细胞增殖和迁移做出贡献。系统生物学将通过将qBio和cBio工具应用于体外血管生成来预测跨轴信号在血管生成中的作用。将测量配体、受体和接头的浓度,并预测跨轴信号的大小。这些预测将通过展示在体外对血管形成的控制(抑制和刺激)来验证。这项研究将与教学相结合,通过核心课程创建本科生研究途径。这将向二年级学生介绍系统生物学,他们将开发血管生成中配体-受体信号的计算模型。学生还将有机会在国际和平研究所的研究实验室继续他们的工作。将为人数不足的学生提供额外的辅导,以支持他们在STEM领域的坚持不懈。
英文摘要
PI: Imoukhuede, PrincessProposal #: 1653925A critical challenge in biomedical engineering is a need to control the process of blood vessel formation, also known as "angiogenesis." Controlling angiogenesis is important, because blood vessels supply the nutrients necessary for our organs and tissues to function properly. Efforts to control angiogenesis in cancer focus on starving and possibly killing the tumor by cutting off tumor blood supply, typically by looking at a single protein. This project proposes to overcome current limitations in this type of cancer therapy and meet the general challenge of controlling angiogenesis by tackling a more difficult, "big-data"-like problem: understanding how combinations of proteins control angiogenesis. This project will tackle the problem by: 1) experimentally determining important protein characteristics; 2) determining mathematical equations that describe the behaviors of these proteins; and 3) developing computer simulations that include both the experimental data and the mathematical equations to determine how the proteins work to cause angiogenesis. The education and outreach portion of this project will introduce sophomores to research and computer modeling in an introductory-level course in order to excite them about STEM. The activities will include mentoring of underrepresented students to increase their interest and persistence within STEM majors.The directed control of angiogenesis remains a pressing need due to its involvement in the pathology of over 70 diseases. A promising approach for angiogenesis control involves going beyond the traditional emphasis on the vascular endothelial growth factor (VEGF)-VEGF receptor (VEGFR) axis towards a new focus: cross-axis signaling (protein binding across families). The objective in this project is to pioneer a shift towards understanding cross-axis angiogenic signaling via three aims grounded in quantitative biology (qBio), omputational biology (cBio), and integrative systems biology (sBio). Quantitative biology will be used to measure cross-axis binding and concentrations or relevant protein ligands, including through the development of new quantitative tools for multiplex measurement of receptor concentrations. Computational biology will be used to construct validated cross-axis models that will predict how adapter activation contributes to angiogenic hallmarks, cell proliferation, and migration. Systems biology will be used to predict the role of cross-axis signaling in angiogenesis by applying the qBio and cBio tools to angiogenesis in vitro. Ligand, receptor, and adapterconcentrations will be measured, and the magnitude of cross-axis signaling will be predicted. These predictions will be validated bydemonstrating control of vessel formation (inhibition and stimulation) in vitro. This research will be integrated with teaching by creating undergraduate research pathways via a core course. This will introduce systems biology to sophomore students who will develop computational models of ligand-receptor signaling in angiogenesis. Students will also be offered opportunities to continue their work within the PI's research laboratory. Additional mentoring will be provided to underrepresented students to support their persistence within STEM fields.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Innovation and Entrepreneurship in Promotion and Tenure in Biomedical Engineering: Communication from the Biomedical Engineering Society Long Range Planning Committee
生物医学工程学会晋升和终身教职的创新创业:来自生物医学工程学会长期规划委员会的通讯
DOI: 10.1007/s12195-023-00767-x
发表时间: 2023
期刊: Cellular and Molecular Bioengineering
影响因子: 2.8
作者: [Kohs, Tia C., Clarin, Samuel N., Carter, Rich G., Mundorff, Karl, Imoukhuede, Princess I., Ramamurthi, Anand, Bao, Gang, King, Michael R., McCarty, Owen J.]
通讯作者: McCarty, Owen J.
DOI: 10.1016/j.heliyon.2024.e25761
发表时间: 2024-02-15
期刊: HELIYON
影响因子: 4
作者: [Fang,Yingye, Reinl,Erin L., Imoukhuede,Princess I.]
通讯作者: Imoukhuede,Princess I.
CAREER: qBio+cBio=sBio; Identifying the role of cross-family signaling in angiogenesis
  • 批准号:
    1923151
  • 项目类别:
    Standard Grant
  • 资助金额:
    $36.8万
  • 财政年份:
    2018
  • 负责人:
    Princess Imoukhuede
  • 依托单位:
CAREER: qBio+cBio=sBio; Identifying the role of cross-family signaling in angiogenesis
UNS:ADVANCING CELL-PRESERVING SEPARATION VIA DETACHABLE CELL ANCHORING & SPIRAL MICRO-MIXING
海外基金